Antithrombotic Therapy in Peripheral Artery Disease: Stepping in the Right Direction

Literature review of randomized studies using PubMed and MEDLINE databases. The preferred therapy for symptomatic patients with peripheral artery disease (PAD) not scheduled for intervention is aspirin. For patients undergoing endovascular revascularization, the preferred therapy is dual antiplatelet therapy using aspirin (ASA) and clopidogrel (Plavix) for at least the first month followed by long-term single antiplatelet therapy. For patients...